Shattuck Labs In
STTK·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$6.73
Today
-1.6%
YTD
+83.7%
About
Shattuck Labs Incorporated, a clinical-stage biotechnology enterprise, researches and develops bi-functional proteins for the treatment of cancer and autoimmune diseases. The company, founded in 2016, is based in Austin, Texas, and operates in the United States. Shattuck trades on the NASDAQ GS under the STTK ticker. Follow this item on eToro to receive updates on STTK price indicators.
Price chart
Closing price history for STTK (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-13.22
P/S (TTM)873.41
P/B (TTM)3.21
Market cap$675.44M
Cap tierSmall-cap
Industry avg P/E-2.03
Profitability
Gross margin-256.50%
EBIT margin-5570.60%
Net margin-1005.60%
ROE-39.21%
ROA-36.88%
Earnings & Revenue
Revenue (TTM)$1.00M
Revenue growth (1Y)-66.6%
EPS (TTM)-$0.51
Free cash flow$-41.24M
Total debt$2.67M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.86
Employees40
Next earnings12 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.